Applying immunotherapy in clinical practice for patients with early stage NSCLC

🔍 Transforming early-stage NSCLC care: Practical immunotherapy insights

Immunotherapy is now a cornerstone in the management of early-stage non-small cell lung cancer (NSCLC), but how can we use it most effectively in clinical practice?

In this expert-led activity, thoracic surgeon Prof. Jonathan Spicer shares real-world guidance on how to integrate immunotherapy across neoadjuvant, perioperative and adjuvant settings.

🎯 You’ll gain insights into:

• Where immunotherapy fits in pre- and post-surgical treatment pathways
• How to select and sequence treatments effectively
• Practical considerations for tailoring care to each patient

📽️ Watch the expert session now: https://touchoncologyime.org/touchexp...

Stay informed. Treat with confidence. Deliver optimal outcomes.

This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.

The activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

#NSCLC #LungCancer #Immunotherapy #OncologyEducation #CancerCare #ClinicalPractice #MedicalEducation #HCPLearning